Enterprise Value
34.8M
Cash
1.252M
Avg Qtr Burn
-4.901M
Short % of Float
3.92%
Insider Ownership
17.45%
Institutional Own.
6.58%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PURE EP™ (device) Details Medical device, Heart disease | Approved Quarterly sales | |
Merimepodib (MMPD) Details COVID-19 | Failed Discontinued |